# A Study to Assess Efficacy and Tolerability of Topical Skincare Products on Psoriasis Patients

> **NCT06357221** · PHASE4 · COMPLETED · sponsor: **Galderma R&D** · enrollment: 46 (actual)

## Conditions studied

- Plaque Psoriasis
- Psoriasis

## Interventions

- **DRUG:** Cetaphil

## Key facts

- **NCT ID:** NCT06357221
- **Lead sponsor:** Galderma R&D
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-04-08
- **Primary completion:** 2024-07-18
- **Final completion:** 2024-07-18
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2024-10-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06357221

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06357221, "A Study to Assess Efficacy and Tolerability of Topical Skincare Products on Psoriasis Patients". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT06357221. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*